Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics

被引:86
作者
Ringberg, A [1 ]
Anagnostaki, L
Anderson, H
Idvall, I
Fernö, M
机构
[1] Malmo Univ Hosp, Dept Plast & Reconstruct Surg, SE-20502 Malmo, Sweden
[2] Malmo Univ Hosp, Dept Pathol & Cytol, SE-20502 Malmo, Sweden
[3] Univ Lund Hosp, Dept Canc Epidemiol, S-22185 Lund, Sweden
[4] Univ Lund Hosp, Dept Pathol & Cytol, S-22185 Lund, Sweden
[5] Univ Lund Hosp, Dept Oncol, S-22185 Lund, Sweden
关键词
breast cancer; ductal carcinoma in situ; DCIS; nuclear grade; growth pattern; cell biological factors; prognosis; outcome; recurrence;
D O I
10.1016/S0959-8049(01)00165-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
All cases of ductal carcinoma in situ (DCIS) diagnosed from 1987 to 1991 in the Southern Health Care Region of Sweden, and operated upon with breast conserving treatment (BCT) with (n = 66) or without (n = 121) postoperative radiation (RT) were clinically followed, morphologically re-evaluated and analysed for cell biological factors (immunohistochemical assays or DNA flow cytometry). Median age at diagnosis was 58 years (range 29-83 years) and median follow-up was 62 months. Oestrogen (ER)- and progesterone receptor (PR)-negativity, c-erbB-2 overexpression, low bcl-2 expression, p53 accumulation, DNA non-diploidy and high Ki67, were strongly associated with high grade DCIS, and comedo-type necrosis. In contrast, significant associations to growth pattern (not diffuse versus diffuse) were seen only for c-erbB-2 and PgR. There was also a strong relationship between the cell biological factors, and a summary cell biological index based on principal component analysis was introduced (CBI-7). In the group that had not received postoperative RT, 31 ipsilateral local recurrences occurred (13 invasive, 18 DCIS). Ipsilateral recurrence-free interval (IL-RFI) was in univariate analyses significantly, or almost significantly, shorter for patients showing p53 accumulation, high Ki67 or low bcl-2, compared with patients with normal p53, low Ki67 and high bcl-2. The prognostic importance of the remaining cell biological factors was less pronounced. On the other hand, the index CBI-7, was a strong predictor for recurrence. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1514 / 1522
页数:9
相关论文
共 51 条
[1]   THE GROWTH-PATTERN OF INSITU CARCINOMA IN THE FEMALE BREAST [J].
ANDERSEN, JA ;
NIELSEN, M ;
BLICHERTTOFT, M .
ACTA ONCOLOGICA, 1988, 27 (6A) :739-743
[2]   STATISTICAL EVALUATION OF CELL KINETIC DATA FROM DNA FLOW-CYTOMETRY (FCM) BY THE EM ALGORITHM [J].
BALDETORP, B ;
DALBERG, M ;
HOLST, U ;
LINDGREN, G .
CYTOMETRY, 1989, 10 (06) :695-705
[3]   OVEREXPRESSION OF THE C-ERBB-2 ONCOPROTEIN - WHY DOES THIS OCCUR MORE FREQUENTLY IN DUCTAL CARCINOMA INSITU THAN IN INVASIVE MAMMARY-CARCINOMA AND IS THIS OF PROGNOSTIC-SIGNIFICANCE [J].
BARNES, DM ;
BARTKOVA, J ;
CAMPLEJOHN, RS ;
GULLICK, WJ ;
SMITH, PJ ;
MILLIS, RR .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (2-3) :644-648
[4]   DUCTAL CARCINOMA IN-SITU - ASSESSMENT OF NECROSIS AND NUCLEAR MORPHOLOGY AND THEIR ASSOCIATION WITH BIOLOGICAL MARKERS [J].
BOBROW, LG ;
HAPPERFIELD, LC ;
GREGORY, WM ;
MILLIS, RR .
JOURNAL OF PATHOLOGY, 1995, 176 (04) :333-341
[5]   c-erbB-3 protein expression in ductal carcinoma in situ of the breast [J].
Bobrow, LG ;
Millis, RR ;
Happerfield, LC ;
Gullick, WJ .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (11) :1846-1850
[6]  
Boyages J, 1999, CANCER, V85, P616, DOI 10.1002/(SICI)1097-0142(19990201)85:3<616::AID-CNCR12>3.3.CO
[7]  
2-Z
[8]   PATHOLOGICAL PROGNOSTIC FACTORS IN BREAST-CANCER .1. THE VALUE OF HISTOLOGICAL GRADE IN BREAST-CANCER - EXPERIENCE FROM A LARGE STUDY WITH LONG-TERM FOLLOW-UP [J].
ELSTON, CW ;
ELLIS, IO .
HISTOPATHOLOGY, 1991, 19 (05) :403-410
[9]   Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial [J].
Fisher, B ;
Dignam, J ;
Wolmark, N ;
Wickerham, DL ;
Fisher, ER ;
Mamounas, E ;
Smith, R ;
Begovic, M ;
Dimitrov, NV ;
Margolese, RG ;
Kardinal, CG ;
Kavanah, MT ;
Fehrenbacher, L ;
Oishi, RH .
LANCET, 1999, 353 (9169) :1993-2000
[10]   Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from national surgical adjuvant breast and bowel project B-17 [J].
Fisher, B ;
Dignam, J ;
Wolmark, N ;
Mamounas, E ;
Costantino, J ;
Poller, W ;
Fisher, ER ;
Wickerham, DL ;
Deutsch, M ;
Margolese, R ;
Dimitrov, N ;
Kavanah, M .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) :441-452